Previous 10 | Next 10 |
home / stock / nvax / nvax articles
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.36% on an annualized basis producing an average annual return of 29.0...
Novavax, Inc. (NASDAQ:NVAX) shares are moving higher on Monday. Here’s what you need to know. What To Know: The company announced on July 2 t...
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 6.35% on an annualized basis producing an average annual return of 19.29...
Novavax (NASDAQ: NVAX) submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its protein-based COV...
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio (NASDAQ:TWLO). On June 14, Morgan Stan...
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profi...
Moderna, Inc. (NASDAQ: MRNA) announced that it has submitted an application to the FDA seeking approval of its Spikevax 2024-2025 formula, tar...
These mid-cap stocks were the best performers in the last week. Are they in your portfolio? Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares soared ...
Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results ...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...